← back to search

Viji Nair

University of Michigan–Ann Arbor · US
Area of research
Nephrology · Molecular Biology
Research interest
Research interests include Medicine, Diabetes mellitus, Disease, Kidney disease, Internal medicine, and Endocrinology.
h-index
citations
3,208
works
28
NIH funding
primary concept
email

Recent publications

Leveraging complementary multi-omics data integration methods for mechanistic insights in kidney diseases
JCI Insight 2025cited by 12position: middledoi
SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes
Journal of Clinical Investigation 2023cited by 103position: middledoi
The deacylase sirtuin 5 reduces malonylation in nonmitochondrial metabolic pathways in diabetic kidney disease
Journal of Biological Chemistry 2023cited by 26position: middledoi
Tubular dysfunction impairs renal excretion of pseudouridine in diabetic kidney disease
American Journal of Physiology-Renal Physiology 2023cited by 9position: middledoi
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
Kidney International 2022cited by 87position: middledoi
Genome-wide meta-analysis and omics integration identifies novel genes associated with diabetic kidney disease
Diabetologia 2022cited by 68position: middledoi
Epigenome-wide meta-analysis identifies DNA methylation biomarkers associated with diabetic kidney disease
Nature Communications 2022cited by 49position: middledoi
Urinary Proteomics Identifies Cathepsin D as a Biomarker of Rapid eGFR Decline in Type 1 Diabetes
Diabetes Care 2022cited by 36position: middledoi
Molecular Characterization of Membranous Nephropathy
Journal of the American Society of Nephrology 2022cited by 30position: middledoi
Multi-Scalar Data Integration Links Glomerular Angiopoietin-Tie Signaling Pathway Activation With Progression of Diabetic Kidney Disease
Diabetes 2022cited by 17position: middledoi
Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy
Kidney International 2021cited by 111position: middledoi
Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs
Journal of Clinical Investigation 2021cited by 59position: middledoi
Comprehensive Search for Novel Circulating miRNAs and Axon Guidance Pathway Proteins Associated with Risk of ESKD in Diabetes
Journal of the American Society of Nephrology 2021cited by 43position: middledoi
Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease
Metabolomics 2021cited by 20position: middledoi
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes
Nature Medicine 2019cited by 431position: middledoi
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen
Journal of the American Society of Nephrology 2019cited by 213position: middledoi
ATP-binding cassette A1 deficiency causes cardiolipin-driven mitochondrial dysfunction in podocytes
Journal of Clinical Investigation 2019cited by 174position: middledoi
Increased lipogenesis and impaired β-oxidation predict type 2 diabetic kidney disease progression in American Indians
JCI Insight 2019cited by 120position: middledoi
Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children
Kidney International 2019cited by 61position: middledoi
Identification of glomerular and podocyte-specific genes and pathways activated by sera of patients with focal segmental glomerulosclerosis
PLoS ONE 2019cited by 29position: middledoi
An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome
The American Journal of Human Genetics 2018cited by 184position: middledoi
Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy
Journal of the American Society of Nephrology 2017cited by 88position: middledoi
Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications
JCI Insight 2016cited by 261position: middledoi
Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker
Science Translational Medicine 2015cited by 429position: middledoi
Genome-Wide Association and Trans-ethnic Meta-Analysis for Advanced Diabetic Kidney Disease: Family Investigation of Nephropathy and Diabetes (FIND)
PLoS Genetics 2015cited by 165position: middledoi
Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects
Journal of the American Society of Nephrology 2015cited by 135position: middledoi
MicroRNA-21 in Glomerular Injury
Journal of the American Society of Nephrology 2014cited by 140position: middledoi
Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease
Journal of the American Society of Nephrology 2013cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Matthias Kretzler · University of Bristol16 papers (2013–2025)Robert G. Nelson · Institute of Nutrition, Metabolism and Diabetes8 papers (2014–2023)Frank C. Brosius · University of Arizona8 papers (2014–2025)Subramaniam Pennathur · University Medical Center6 papers (2019–2025)Markus Bitzer · University of Michigan–Ann Arbor4 papers (2014–2025)Wenjun Ju · University of Georgia4 papers (2014–2025)Helen C. Looker · National Institute of Diabetes and Digestive and Kidney Diseases4 papers (2019–2021)Sean Eddy · The Ohio State University Wexner Medical Center4 papers (2019–2025)Kevin L. Duffin · Eli Lilly (United States)3 papers (2019–2025)Kelli M. Sas · The Ohio State University Wexner Medical Center2 papers (2021–2023)Laura H. Mariani · Kobe University2 papers (2015–2022)Alessandro Doria · Harvard University2 papers (2019–2021)Alessia Fornoni · University of Miami2 papers (2019–2019)Jaeman Byun · University of Michigan–Ann Arbor2 papers (2019–2023)Fadhl Alakwaa · University of Michigan–Ann Arbor2 papers (2023–2025)Farsad Afshinnia · University of Michigan–Ann Arbor2 papers (2019–2023)Monika A. Niewczas · Joslin Diabetes Center2 papers (2019–2021)Meda E. Pavkov · Centers for Disease Control and Prevention2 papers (2019–2021)Jiahe Lin · University of Michigan–Ann Arbor2 papers (2019–2021)Edgar A. Otto · Broad Institute2 papers (2015–2023)